Industry veteran brings more than 30 years of experience launching therapies for neurological diseases, including Huntington's disease, and will prepare Skyhawk for the launch of SKY-0515 as early as ...

Australia's Therapeutic Goods Administration (TGA), responsible for approval of the safety, quality, and efficacy of therapeutic goods, has determined that Skyhawk's SKY-0515 orally-administered small ...

The sovereign citizen movement has spread from the United States to more than 26 countries globally. Covid restrictions and digital networks accelerated its growth and created dangerous intersections ...

Skyhawk Therapeutics has announced positive interim results from its phase 1 trial of SKY-0515, an investigational treatment for Huntington’s disease. The phase 1 clinical trial of SKY-0515 showed ...

A small Cessna plane flipped during a takeoff attempt at the Augusta Municipal Airport on Saturday morning. The sole occupant, a pilot from Wichita, was not injured. A single-engine 2023 Cessna ...

The A-4 Skyhawk was designed as a small and nimble dogfighter—the same design principles used for Soviet aircraft, making it useful as a stand-in. The aircraft people remember from the film Top Gun is ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

Peter earned a Bachelor of Archeology and Creative Writing from the University of Alabama and has since joined his love of driving and riding with storytelling. His voice is full of southern ...

Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars. He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and ...

When Citizen released The Citizen reference AQ4100-57B in late 2024, it inevitably drew comparisons to the iconic Grand Seiko SBGA211 Snowflake. The intricately decorated dial, featuring metallic ...

Merck KGaA agreed to collaborate with Skyhawk Therapeutics Inc. to develop neurological therapies in a deal that could be valued at more than $2 billion as the German company seeks to bolster its drug ...